Table 1 Case Study Companies
From: Corporate social responsibility to improve access to medicines: the case of Brazil
Company | Ownership status | Founded | Size (employees) | Products |
|---|---|---|---|---|
1. Ache Farmaceutica [39] | Publicly-traded | 1961 | >2000 | Generics, branded generics, and innovative |
2. Apsen Farmaceutica [40] | Private | 1969 | ~700 | Generics, branded generics, and early stage innovative |
3. Biolab Sanus Farmaceutica [41] | Private | 1997 | 2000 | Branded generics, innovative |
4. EMS [42] | Private, family-owned | 1964 | >4500 | Generics, branded generics, innovative |
Public (government) | 1900 as public health agency, pharmaceutical divisions founded in 1976 | Generics for government purchase only | ||
6. Eurofarma [45] | Private | 1972 | >6000 | Generics, branded generics, innovative |